Showing results (21-30 of 66) with videos related to
Sort By:
Pageof 7
Neurobiology of Disease|April 20, 2005
A human single-chain Fv intrabody preferentially targets amino-terminal Huntingtin's fragments in striatal models of Huntington's diseaseTodd W Miller, Chun Zhou, Silvia Gines, et al.American Journal of Physical Anthropology|February 1, 1997
Mitochondrial versus nuclear admixture estimates demonstrate a past history of directional matingD A Merriwether, S Huston, S Iyengar, et al.Bio/Technology (Nature Publishing Company)|September 1, 1994
Mammalian cell expression of single-chain Fv (sFv) antibody proteins and their C-terminal fusions with interleukin-2 and other effector domainsH Dorai, J E McCartney, R M Hudziak, et al.Journal of Protein Chemistry|December 1, 1991
Biosynthetic antibody binding sites: development of a single-chain Fv model based on antidinitrophenol IgA myeloma MOPC 315J E McCartney, L Lederman, E A Drier, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Avidity-mediated enhancement of in vivo tumor targeting by single-chain Fv dimersGregory P Adams, Mei-Sheng Tai, John E McCartney, et al.Cell Biophysics|June 1, 1995
Redirection of cellular cytotoxicity. A two-step approach using recombinant single-chain Fv moleculesA J George, J A Titus, C R Jost, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1994
Redirection of T cell-mediated cytotoxicity by a recombinant single-chain Fv moleculeA J George, J A Titus, C R Jost, et al.Journal of Molecular Biology|April 12, 2015
Structure of a single-chain Fv bound to the 17 N-terminal residues of huntingtin provides insights into pathogenic amyloid formation and suppressionErwin De Genst, Dimitri Y Chirgadze, Fabrice A C Klein, et al.Cell Biophysics|January 1, 1994
Tumor targeting in a murine tumor xenograft model with the (sFv')2 divalent form of anti-c-erbB-2 single-chain FvJ S Huston, G P Adams, J E McCartney, et al.Proceedings of the National Academy of Sciences of the United States of America|August 1, 1988
Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coliJ S Huston, D Levinson, M Mudgett-Hunter, et al.Pageof 7